We can't find the internet
Attempting to reconnect
15811.2;8 PFLS-LS
Tailoring selectivity profiles for targeted cancer therapy and orphan diseases - PI3K/mTOR drugs
Résumé
Tailoring selectivity profiles for targeted cancer therapy and orphan diseases - PI3K/mTOR drugs
Textes supplémentaires
Abstract
PIQUR and UniBas engage into a project that aims to provide PIQUR access to accelerated drug registration, and UniBas the opportunity to explore PI3K/mTOR-dependent processes in physiology and disease to broaden therapy relevant knowledge and targeting of PI3K/mTOR driven disease processes. Focal themes are differentiation of the PIQUR portfolio, innovative chemistry, and the elucidation of novel biological signaling mechanisms.
Participants
Matthias Wymann
Kontaktperson
matthias.wymann@unibas.ch
Universität Basel Matthias Wymann Mattenstrasse 28 4058 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2013-11-30
- Date de fin
- 2015-11-12
- Coûts totaux approuvés
- CHF 437760.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- T490 Biotechnology 100.0%